Robert M. Davis - 03 May 2022 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
CEO & President, Director
Signature
/s/ Kelly E. W. Grez as Attorney-in-Fact for Robert M. Davis
Issuer symbol
MRK
Transactions as of
03 May 2022
Net transactions value
$0
Form type
4
Filing time
05 May 2022, 16:55:50 UTC
Previous filing
28 Feb 2022
Next filing
09 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MRK Common Stock 247,593 03 May 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRK Stock Option (Right to Buy) Award $0 +228,155 $0.000000 228,155 03 May 2022 Common Stock 228,155 $87.10 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Holdings include shares acquired in dividend reinvestment transactions.
F2 The option vests and becomes exercisable in equal installments on 5/3/2023, 5/3/2024 and 5/3/2025.